NMRA
#3360
Neumora Therapeutics, Inc. - Common Stock
1.5 9 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.63%
Variación mensual
+70.97%
Variación en los últimos 6 meses
-26.05%
Cambio anual
+23.26%
Cierres anteriores
1.6 0
Open
1.5 9
Mínimo
1.5 8
High
1.6 2
Volumen
150
Financials
- Market Capitalization 294.6 M
- Employee 92
- Founded 2019
- CEO N/A
- Website www.neumoratx.com
- Headquarter Delaware, United States
- FIGI BBG012W9C4X1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.23
Relación precio/flujo de caja
-592.04
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3354 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.87 USD | +0.26% | -1.78% | +7.20% | -4.91% | 298.72 M USD | ||
| 3355 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.60 USD | -1.14% | -8.77% | -28.18% | +36.84% | 294.43 M USD | ||
| 3386 |  MGNX MacroGenics, Inc. - Common Stock | 4.38 USD | -2.67% | -1.35% | +10.61% | +178.98% | 278.41 M USD | ||
| 3390 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.76 USD | +0.80% | -0.53% | +9.30% | +55.37% | 287.50 M USD |